Suppression of La antigen exerts potential antiviral effects against hepatitis A virus.

Suppression of La antigen exerts potential antiviral effects against hepatitis A virus.

BACKGROUND:Despite the development and availability of hepatitis A virus (HAV) vaccine, HAV infection is still a major cause of acute hepatitis that occasionally leads to fatal liver disease. HAV internal ribosomal entry-site (IRES) is one of the attractive targets of antiviral agents against HAV. T...

Full description

Bibliographic Details
Main Authors:	Xia Jiang, Tatsuo Kanda, Shuang Wu, Shingo Nakamoto, Kengo Saito, Hiroshi Shirasawa, Tomoko Kiyohara, Koji Ishii, Takaji Wakita, Hiroaki Okamoto, Osamu Yokosuka
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4084951?pdf=render

Similar Items

Hepatitis C virus nonstructural protein 5A inhibits thapsigargin-induced apoptosis.
by: Xia Jiang, et al.
Published: (2014-01-01)

Hepatitis C Virus Nonstructural Protein 5A Inhibits MG132-Induced Apoptosis of Hepatocytes in Line with NF-κB-Nuclear Translocation.
by: Xia Jiang, et al.
Published: (2015-01-01)

Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha
by: Yang Lingli, et al.
Published: (2010-09-01)

Possible Involvement of Hepatitis B Virus Infection of Hepatocytes in the Attenuation of Apoptosis in Hepatic Stellate Cells.
by: Reina Sasaki, et al.
Published: (2016-01-01)

Hepatic STAT1-nuclear translocation and interleukin 28B polymorphisms predict treatment outcomes in hepatitis C virus genotype 1-infected patients.
by: Tatsuo Miyamura, et al.
Published: (2011-01-01)

No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV.
by: Masato Nakamura, et al.
Published: (2013-01-01)

Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines.
by: Yuki Haga, et al.
Published: (2017-01-01)

Recent Trend of Hepatitis E Virus Infection in Chiba Area, Japan: 3 of 5 Cases with Rheumatoid Arthritis
by: Tatsuo Kanda, et al.
Published: (2015-10-01)

Effect of Hepatitis C Virus Genotype 1b Core and NS5A Mutations on Response to Peginterferon Plus Ribavirin Combination Therapy
by: Shingo Nakamoto, et al.
Published: (2015-09-01)

Serum microRNA-122 and Wisteria floribunda agglutinin-positive Mac-2 binding protein are useful tools for liquid biopsy of the patients with hepatitis B virus and advanced liver fibrosis.
by: Masato Nakamura, et al.
Published: (2017-01-01)

Reactivation of Hepatitis B Virus in Hematopoietic Stem Cell Transplant Recipients in Japan: Efficacy of Nucleos(t)ide Analogues for Prevention and Treatment
by: Shingo Nakamoto, et al.
Published: (2014-11-01)

Roles of ITPA and IL28B Genotypes in Chronic Hepatitis C Patients Treated with Peginterferon Plus Ribavirin
by: Osamu Yokosuka, et al.
Published: (2012-08-01)

HBV Core Protein Enhances Cytokine Production
by: Tatsuo Kanda, et al.
Published: (2015-09-01)

MicroRNA-122 Inhibits the Production of Inflammatory Cytokines by Targeting the PKR Activator PACT in Human Hepatic Stellate Cells.
by: Masato Nakamura, et al.
Published: (2015-01-01)

Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Could Not Always Predict Early Cirrhosis in Non-Viral Liver Diseases
by: Yuki Haga, et al.
Published: (2016-12-01)

Hepatitis C Virus and Hepatocellular Carcinoma
by: Masao Omata, et al.
Published: (2013-01-01)

Treatment of hepatitis C virus infection in the future
by: Tatsuo Kanda, et al.
Published: (2013-12-01)

Faldaprevir for the Treatment of Hepatitis C
by: Tatsuo Kanda, et al.
Published: (2015-03-01)

Acute Liver Failure Associated with Propylthiouracil in a Pregnant 26-Year-Old Woman
by: Tatsuo Miyamura, et al.
Published: (2013-05-01)

Acute Liver Injury in a Patient with Alcohol Dependence: A Case Resembling Autoimmune Hepatitis or Drug-Induced Liver Injury
by: Masahiro Hayashi, et al.
Published: (2014-04-01)

Occurrence and Recurrence of Hepatocellular Carcinoma Were Not Rare Events during Phlebotomy in Older Hepatitis C Virus-Infected Patients
by: Tatsuo Kanda, et al.
Published: (2014-05-01)

Hepatitis B Virus Genotype C is Predominant in Myanmar
by: Nan Nwe Win, et al.
Published: (2017-12-01)

Drug-Induced Liver Injury Associated with Complementary and Alternative Medicines
by: Koji Takahashi, et al.
Published: (2016-11-01)

Discrepancy between Hepatitis C Virus Genotypes and NS4-Based Serotypes: Association with Their Subgenomic Sequences
by: Nan Nwe Win, et al.
Published: (2017-01-01)

Efficacy of Lamivudine or Entecavir on Acute Exacerbation of Chronic Hepatitis B
by: Tatsuo Kanda, Masami Shinozaki, Hidehiro Kamezaki, Shuang Wu, Shingo Nakamoto, Makoto Arai, Keiichi Fujiwara, Nobuaki Goto, Fumio Imazeki, Osamu Yokosuka
Published: (2012-01-01)

New treatments for genotype 1 chronic hepatitis C – focus on simeprevir
by: Kanda T, et al.
Published: (2014-05-01)

Prevalence of hepatitis C virus subgenotypes 1a and 1b in Japanese patients: ultra-deep sequencing analysis of HCV NS5B genotype-specific region.
by: Shuang Wu, et al.
Published: (2013-01-01)

Impact of Aging on Liver Histological Findings of Autoimmune Liver Diseases
by: Yuki Haga, et al.
Published: (2014-11-01)

Antiviral activity of glycyrrhizin against hepatitis C virus in vitro.
by: Yoshihiro Matsumoto, et al.
Published: (2013-01-01)

Antiviral Activity Exerted by Natural Products against Human Viruses
by: Maria Musarra-Pizzo, et al.
Published: (2021-05-01)

Sustained Virological Response after 8-Week Treatment of Simeprevir with Peginterferon α-2a plus Ribavirin in a Japanese Female with Hepatitis C Virus Genotype 1b and IL28B Minor Genotype
by: Tatsuo Kanda, et al.
Published: (2015-07-01)

Treatment of Real-World HCV Genotype 2-Infected Japanese Patients with Sofosbuvir plus Ribavirin
by: Tatsuo Kanda, et al.
Published: (2017-05-01)

Analysis of 5' nontranslated region of hepatitis A viral RNA genotype I from South Korea: comparison with disease severities.
by: Tatsuo Kanda, et al.
Published: (2010-01-01)

Successful Management of Graft Reinfection of HCV Genotype 2 in Living Donor Liver Transplantation from a Hepatitis B Core Antibody-Positive Donor with Sofosbuvir and Ribavirin
by: Reina Sasaki, et al.
Published: (2016-07-01)

Successful Eradication of Hepatitis C Virus by Interferon-Free Regimens in Two Patients with Advanced Liver Fibrosis following Kidney Transplantation
by: Reina Sasaki, et al.
Published: (2016-05-01)

Matrix Metalloproteinase 9 Exerts Antiviral Activity against Respiratory Syncytial Virus.
by: Abdoulaye J Dabo, et al.
Published: (2015-01-01)

Peginterferon Alfa-2a plus Ribavirin in Japanese Patients Infected with Hepatitis C Virus Genotype 2 Who Failed Previous Interferon Therapy
by: Tatsuo Kanda, Shingo Nakamoto, Takayoshi Nishino, Nobuo Takada, Akihito Tsubota, Keizo Kato, Tatsuo Miyamura, Daisuke Maruoka, Shuang Wu, Takeshi Tanaka, Makoto Arai, Shigeru Mikami, Keiichi Fujiwara, Fumio Imazeki, Osamu Yokosuka
Published: (2013-01-01)

IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens
by: Tatsuo Miyamura, et al.
Published: (2014-01-01)

Epigenetic reprogramming promotes the antiviral action of IFNα in HBV-infected cells
by: Luc Gailhouste, et al.
Published: (2021-06-01)

Exosomes and Hepatocellular Carcinoma: From Bench to Bedside
by: Reina Sasaki, et al.
Published: (2019-03-01)